Preventive screening in Canada is guided by national evidence-based recommendations (historically from the Canadian Task Force on Preventive Health Care, with a new national advisory committee now assuming guideline development) as well as provincial cancer screening programs. Recommendations may vary slightly by province and according to personal risk factors such as family history, smoking, or genetic conditions.
| Screening | Who Should Be Screened | Frequency |
|---|---|---|
| Blood pressure | Adults ≥18 years | At regular healthcare visits |
| Type 2 diabetes | Adults at increased risk (using risk assessment such as CANRISK) | Every 3–5 years or as advised |
| Colorectal cancer | Adults aged 45–74 (Ontario) | FIT (fecal immunochemical test) every 2 years |
| Breast cancer | Women aged 40–74 | Mammogram every 2–3 years, beginning at age 40 |
| Cervical cancer | People with a cervix aged 25–69 | HPV test or Pap test every 3–5 years depending on provincial program |
| Lung cancer | Adults at high risk (heavy smokers/former smokers) | Annual low-dose CT if eligible |
| Abdominal aortic aneurysm (AAA) | Men aged 65–80 who have ever smoked | One-time ultrasound |
| Osteoporosis | Women ≥65 years; younger adults at increased fracture risk | Bone mineral density testing based on fracture risk |
High blood pressure usually has no symptoms but is a leading driver of heart attack, stroke, and kidney disease. Hypertension Canada defines hypertension as blood pressure at or above 130/80 mmHg and recommends routine blood pressure checks at primary care visits, with home or automated office monitoring used to confirm a diagnosis.
A lipid panel helps estimate long-term cardiovascular risk. Canadian guidelines generally recommend cholesterol screening for adults starting around age 40 (or earlier with risk factors such as diabetes, family history, smoking, or obesity), with statin therapy considered for those at elevated risk.
Type 2 diabetes can develop silently for years. Diabetes Canada recommends screening adults starting at age 40, and earlier or more frequently for those with risk factors like obesity, hypertension, a family history of diabetes, or belonging to a higher-risk ethnic group. Screening is typically done with a fasting blood glucose or A1c test.
Current Canadian Task Force on Preventive Health Care guidance recommends routine Pap testing every 3 years for women and people with a cervix aged 25–69 who are or have been sexually active. Screening is not routinely recommended under age 25. Those aged 70+ with a history of adequate prior screening may be able to stop.
This clinic recommends mammography beginning at age 40, in line with the Canadian Cancer Society's position, rather than waiting until age 50. Canada's national screening guideline body was restructured in 2025–2026 in part over disagreement on this exact question, and recommendations are still evolving. The right frequency and approach for you should be discussed directly with Dr. Vasandani, taking your personal and family history into account.
As of July 1, 2026, Ontario's ColonCancerCheck program lowered the starting age for average-risk adults from 50 to 45, following similar changes in other provinces. Adults aged 45–74 in Ontario are now eligible for a fecal immunochemical test (FIT) every 2 years, with colonoscopy reserved for higher-risk individuals or abnormal results. This change followed rising colorectal cancer rates in adults under 50 and is expected to open screening access to over a million more Ontarians. Anyone with a family history or symptoms (rectal bleeding, unexplained weight loss, persistent changes in bowel habits) should be screened earlier, regardless of age.
Routine vaccines recommended for most healthy adults in Canada include:
Exact recommendations and public funding vary by province. Talk to Dr. Vasandani about which vaccines are right for your age, health history, and risk factors.
Screening recommendations are not fixed — they shift as new evidence emerges. Canada's federal task force on preventive health care was paused in 2025 amid concerns it was too slow to update breast cancer screening guidance, and a new National Advisory Committee on Preventive Health Services launched in 2026 to modernize these recommendations. This is a normal part of how medicine improves over time, but it does mean published "standard" ages and intervals can lag behind what individual specialists or advocacy organizations recommend.
Because screening guidelines depend heavily on age, sex, family history, and personal risk factors — and because official guidance is actively being updated — the most reliable approach is a personalized screening and immunization plan built with Dr. Vasandani, rather than relying solely on general public guidance.
This information is for general educational purposes and reflects publicly available guidance as of 2026. It is not a substitute for personalized medical advice.